Mylan launches thiamine-deficiency drug

PITTSBURGH — Mylan has launched a generic drug for treating thiamine deficiency, the company said Thursday.



The generic drug maker announced the launch of thiamine hydrochloride injection in the 100-mg-per-mL strength, packaged in 25-vial packs of 200-mg-per-2-mL multiple-dose vials.



The drug had sales of about $18.6 million during the 12-month period ended in March, according to IMS Health. Mylan said it would ship the drug immediately.

Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.